Sunshine Biopharma Inc (SBFM)

[aks_v]

SBFM has huge potential

http://sunshinebiopharma.com/company.html

http://sunshinebiopharma.com/drugs-development.html

Read this section. It states that Clinical Trials will be started and although the trials is conducted in canada, it will still be compatible with FDA guidelines. Looks like Atlas Pharm's registration with FDA is very critical as the trials downstream phase might require drug dev using Atlas's collaboration

Adva-27a Clinical Trials Plans:

Adva-27a’s initial indication for Phase I clinical trials will be pancreatic cancer. We are planning to conduct our clinical trials at McGill University’s Jewish General Hospital in Montreal, Canada. All aspects of the planned clinical trials in Canada will employ FDA standards at all levels. We estimate that it will take approximately 18 to 24 months from start to finish. Following successful completion of Phase I clinical trials, it is likely that we will be required to make Adva-27a available to patients under the “compassionate-use” guidelines.